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FluorescenceEscherichia coli multidrug resistance protein E (EmrE) is a four transmembrane α-helix protein, and a
member of the small multidrug resistance protein family that confers resistance to a broad range of
quaternary cation compounds (QCC) via proton motive force. The multimeric states of EmrE protein during
transport or ligand binding are variable and speciﬁc to the conditions of study. To explore EmrE
multimerization further, EmrE extracted from E. coli membranes was solubilized in anionic detergent,
sodium dodecyl sulphate (SDS), at varying protein concentrations. At low concentrations (≤1 μM) in SDS–
EmrE is monomeric, but upon increasing EmrE concentration, a variety of multimeric states can be observed
by SDS-Tricine polyacrylamide gel electrophoresis (PAGE). Addition of the (QCC), tetraphenyl phosphonium
(TPP), to SDS–EmrE samples enhanced EmrE multimer formation using SDS-Tricine PAGE. The relative
shapes of EmrE multimers in SDS with or without TPP addition were determined by small angle neutron
scattering (SANS) analysis and revealed that EmrE dimers altered in conformation depending on the SDS
concentration. SANS analysis also revealed that relative shapes of larger EmrE multimers (≥100 nm sizes)
altered in the presence of TPP. Circular dichroism spectropolarimetry displayed no differences in secondary
structure under the conditions studied. Fluorescence spectroscopy of SDS–EmrE protein demonstrated that
aromatic residues, Trp and Tyr, are more susceptible to SDS concentration than TPP addition, but both
residues exhibit enhanced quenching at high ligand concentrations. Hence, EmrE forms various multimers in
SDS that are inﬂuenced by detergent concentration and TPP substrate addition.ing, 2500UniversityDriveN.W.,
lgary, Alberta, CanadaT2N1N4.
ll rights reserved.© 2009 Elsevier B.V. All rights reserved.1. Introduction
Ethidium multidrug resistance protein (EmrE) is a member of the
small multidrug resistance (SMR) protein family that actively efﬂuxes
a broad range of quaternary cation compounds (QCC) by proton
motive force [1–3]. SMR protein family members are part of the
drug/metabolite transporter (DMT) superfamily which consists of 14
phylogenetically distinct protein families [4,5]. Members of the SMR
family are unique from other DMT superfamily members for two
important reasons. Firstly, SMR sequences are frequently identiﬁed
within the conserved regions of Class 1 and 2 integrons (for examples
refer to [6,7]) indicating that members of the SMR protein family are
highly transmissible via lateral gene transfer. Secondly, SMR proteins
are distinct from much larger multidrug transporters (composed of
8 to 22 transmembrane (TM) strands) due to their short length of
approximately 100–150 amino acids and form 4 TM α-helix strandswithin the plasma membrane. These proteins are very hydrophobic
and possess a highly conserved negatively charged residue (Glu14
according to Escherichia coli EmrE) within the ﬁrst TM strand that is
responsible for its ligand binding activity (as reviewed by [8,9]). E coli
EmrE serves as the paradigm SMR protein for both functional and
structural studies since it is the only member tested extensively
biochemically (as reviewed by [9]) and to have yielded high
resolution structures by 3-dimensional X-ray crystal diffraction [10]
and 3D cryo-electron microscopic analysis of two-dimensional (2D)
crystals [11–14]. Despite these achievements, controversy still
engulfs EmrE structural elucidation largely due to the difﬁculties
conﬁdently linking EmrE biochemical data to the high resolution
structures [15–18].
One of the numerous problems hindering the structural resolution
of EmrE is the variability in its arrangement within commonly used
membrane mimetics during structural characterization. Studies
examining EmrE multimerization in various membrane mimetic
environments suggest that the protein is functional in an oligomeric
state [19], of which the minimum number of subunits required is a
dimer (as reviewed by [8]). EmrE multimers vary in other studies,
wheremultimeric states such as trimers [20,21] and tetramers [12,13]
Fig. 1. SDS solubilized EmrE proteinmultimerization in the absence and presence of TPP
ligand. Protein bands were separated by SDS-Tricine PAGE (12%) and visualized by UV
absorbance after trichloroethanol (TCE) staining. A total of 3 μg of EmrE protein was
loaded into each gel lane in all panels shown. Arrows on the right hand side of each gel
image correspond to predicted EmrE multimers based on the estimated molecular
weight (MW) of the protein bands in kilodaltons (kDa); monomer (M) 11 kDa, dimer
(D) 22 kDa, trimer (T) 33 kDa, hexamer (H) 66 kDa, octamer (O) 88 kDa, and decamer
(De) 110 kDa. A) EmrE protein re-suspended into 1.0% (w/v) SDS starting from initial
dried EmrE amounts of 0.010 mg (lane 1), 0.025 mg (lane 2), 0.050 mg (lane 3),
0.075 mg (lane 4), 0.100 mg (lane 5), 0.500 mg (lane 6) and 1.000 mg (lane 7) protein.
B) Addition of TPP ligand to 1.0% (w/v) SDS-solubilized 21 μM EmrE protein. TPP was
added to 1.0% (w/v) SDS–21 μM EmrE samples at ﬁnal concentrations ranging from
0.1 mM to 10 mM as indicated above each gel lane.
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experiments for membrane protein characterization. One explanation
for EmrE multimer variation may be a result of folding alterations
caused by the addition of various puriﬁcation fusion tags to the EmrE
protein. Most studies use recombinant SMR proteins possessing FLAG
(DYKDDDDK), myc (EQKLISEEDL), hexahistidinyl (His6) or green
ﬂuorescent protein (GFP) tag fusions at their C-terminus for
topological determination or for protein puriﬁcation (as reviewed
by [8]).
The objective of this study is to examine the multimerization of
untagged EmrE protein solubilized in the simple anionic detergent
sodium dodecyl sulphate (SDS). Previous studies of untagged EmrE
solubilized in SDS indicated that the protein is monomeric but
maintained the ability to bind substrate [22]. Solubilization of most
proteins in SDS is generally denaturing; however, biochemical studies
of a growing number of integral membrane proteins indicate that
membrane proteins are not completely denatured by SDS [23]. Our
early work demonstrated that SDS solubilized EmrE has a slightly
more open structure (by ﬂuorescence) but similar secondary
structure (by circular dichroism) [24]. Hence, further characterization
of SDS–EmrE in the presence and absence of a commonly used
quaternary cation compound (QCC) substrate, tetraphenyl phospho-
nium (TPP), was used to explore EmrE conformations in SDS. The
ligand TPP is a phase-transfer catalyst commonly used in organic/
inorganic synthesis reactions, it is a transportable substrate of EmrE,
and has been used as a compound to induce EmrE crystal formation
for X-ray diffraction techniques (for example [25]). The studies herein
demonstrate that EmrE protein (at low and high concentrations)
solubilized in SDS (at 0.2 and 1.0% w/v) promote a diverse range of
stable multimers shown by SDS-Tricine polyacrylamide gel electro-
phoresis (PAGE) and small angle neutron scattering (SANS). Circular
dichroism spectroscopy conﬁrmed that the protein was α-helix rich
and that secondary structure content was unaffected under the
various conditions studied. Additionally, ﬂuorescence spectroscopic
experiments of SDS–EmrE were performed to determine any
differences in aromatic residue environments within the protein
under various conditions studied here with and without TPP. The
results from these studies indicate that SDS does not completely
denature EmrE protein and that stable multimer forms are present
and dependent on protein concentration, which are capable of
interacting with TPP ligand.
2. Results
2.1. SDS–EmrE multimerization is dependent upon protein concentration
by SDS-Tricine PAGE
In order to examine EmrE multimerization our initial intention
was to screen numerous detergents used in previous experiments for
their ability to promote EmrE multimers. To begin, the anionic
detergent SDS was selected as a simple control system based on
previous experiments that showed that SDS promoted a predomi-
natelymonomeric form of EmrE at low protein concentrations [22,26].
EmrE protein dilutions were prepared, where a starting amount of
1 μg to 10 mg of total protein was dried under N2 gas and re-
suspended into SDS solutions of either 0.2% or 1.0% (w/v). EmrE
protein concentrations at or below 0.25 mg/ml (21 μM) in 0.2% SDS
(data not shown) and 0.10 mg/ml (8.5 μM) in 1.0% SDS resulted in a
predominately monomeric distribution of the protein as determined
by SDS-Tricine PAGE (Fig. 1A). Initial re-suspension amounts of EmrE
in excess of 0.50 mg protein resulted in SDS–EmrE solutions forming
“ladder- like” distributions of EmrE multimers. Based on the
corresponding molecular weight of each protein band (as visualized
by SDS-Tricine PAGE in kilodaltons (kDa)), EmrE was distributed into
monomers (11 kDa), dimers (22 kDa), trimers (33 kDa), hexamers
(66 kDa), octamers (88 kDa) and decamers (110 kDa). Although thepresence of EmrE multimers is apparent, the most abundant form of
the protein resided as a monomer based on the intensity of the EmrE
monomer band on the gel. It is important to note that much larger
EmrE multimers (N110 kDa) were evident, but accurate molecular
weights for these complexes could not be reliably assigned from the
gels.
2.2. SDS–EmrE multimer formation and distribution is altered in the
presence of TPP
To determine if the multimerization ability of EmrE proteins is
altered in the presence of substrate, we examined the effect of
increasing TPP addition to SDS–EmrE protein by SDS-Tricine PAGE.
Incubation of 0.2% and 1.0% (w/v) SDS solubilized EmrE protein at
8.5 μM (0.10 mg/ml) and 21 μM (0.25 mg/ml) concentrations with
1 mMand10 mMligand for 1 hat roomtemperature produceddifferent
amounts of EmrE multimers (Fig. 1B; Table 1). TPP added to either 0.2%
or 1.0% SDS–EmrE (8.5 or 21 μM protein) at a ﬁnal concentration of
1 mM or greater, resulted in an overall increase in all multimer forms
with a concomitant decrease in EmrE monomers (Fig. 1B; Table 1). The
amount of EmrE multimers induced by 0.2% (w/v) SDS–EmrE protein
Table 1
Summary of EmrE multimer distributions in 0.2% and 1.0% SDS detergent with increasing concentrations of TPP by SDS-Tricine PAGE.
EmrE protein
(μM)
TPP
(mM)
Mean EmrE protein multimers observed by SDS-Tricine PAGE
Decamer (110 kDa) Octamer (88 kDa) Hexamer (66 kDa) Trimer (33 kDa) Dimer (22 kDa) Monomer (11 kDa)
0.2% (w/v) SDS
8.5 – – – – 0.01±0.01 0.16±0.04 0.84±0.09
1 – – – 0.02±0.00 0.25±0.03 0.73±0.08
10 – 0.05±0.02 0.07±0.03 0.16±0.02 0.34±0.05 0.38±0.08
21 – – – 0.02±0.01 0.06±0.02 0.27±0.03 0.65±0.05
0.1 – – 0.02±0.01 0.06±0.03 0.27±0.04 0.65±0.08
0.5 – – 0.01±0.00 0.06±0.02 0.27±0.03 0.65±0.06
1 – – 0.02±0.02 0.06±0.04 0.29±0.05 0.62±0.08
5 – 0.01±0.00 0.02±0.00 0.09±0.04 0.44±0.05 0.44±0.09
10 0.02±0.01 0.04±0.03 0.05±0.03 0.16±0.03 0.43±0.12 0.31±0.07
1.0% (w/v) SDS
8.5 – – – 0.02±0.02 0.06±0.06 0.22±0.05 0.69±0.14
1 – – 0.02±0.02 0.07±0.06 0.22±0.05 0.69±0.14
10 0.02±0.02 0.05±0.03 0.07±0.03 0.14±0.03 0.27±0.08 0.44±0.02
21 – – – 0.02±0.02 0.04±0.02 0.22±0.03 0.73±0.04
0.1 – – 0.01±0.02 0.05±0.04 0.24±0.04 0.68±0.10
0.5 – – 0.02±0.01 0.06±0.03 0.24±0.05 0.68±0.10
1 – 0.01±0.01 0.02±0.00 0.07±0.02 0.24±0.05 0.71±0.06
5 – 0.03±0.01 0.03±0.02 0.10±0.03 0.30±0.04 0.56±0.08
10 0.03±0.01 0.06±0.02 0.06±0.02 0.11±0.02 0.29±0.06 0.53±0.05
Protein concentrations: 0.1 mg/ml EmrE=8.5 μM EmrE, 0.25 mg/ml EmrE=21 μM EmrE.
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concentration. A possible explanation for the differences in EmrE
multimerization under low to high SDS concentrations is due to
lower (0.2% w/v; 7 mM) SDS concentrations failing to provide
sufﬁcient micelle coverage for the larger protein complexes. In
particular, EmrE protein at high concentrations (≥0.1 mg/ml;
≥8.5 μM), despite SDS being above the experimentally determined
critical micelle concentration (0.8–1.5 mM in SMR-B buffer). The
concentrations of ligand required to visualize the multimer increase
on SDS-Tricine PAGE were much higher (≤1 mM TPP) than the
previously reported KD values of 4.8 μM for EmrE in SDS [22]. This
indicates that the observed EmrE oligomer stabilization or enhance-
ment requires ligand concentrations far in excess of the KD to
completely saturate all the drug binding sites.
2.3. SANS analysis reveals at least two populations of EmrE multimers in
SDS solution
To determine the dimensions of these EmrE multimer complexes
present, SANS analysis was used to determine the size of EmrE in SDS
detergent. Deuterated SDS (d-SDS) was used in place of hydrogenated
SDS to enhance the contrast between EmrE within the detergent
micelle. If the solvent (water) is contrast-matched (CM) with d-SDS,
we expect to obtain the scattering pattern of EmrE alone (making d-
SDS “invisible” due to the differences in deuterium/hydrogen
scattering angles). Before experiments were performed using d-SDS
solubilized EmrE, examination of the contrast-matching conditions of
SDS scattering conditionswere performed. SANS spectra of 0.2% (w/v)
hydrogenated SDS (h-SDS) and 0.2% (w/v) d-SDS both in SMR-B
bufferedCMwater are shown in Fig. 2A. SDS is known to form spherical
micelles [27], which agree with SANS spectrum of 0.2% (w/v) h-SDS
characterized by a low-q intensity plateau followed by a q−4 decay.
SANS data of the d-SDS solution alone reveals an intensity plateau of
qN0.01 Å−1 (where SDS micelles become almost “invisible”), indicat-
ing a reasonably good CM condition. Therefore, d-SDS contrast-
matching conditions were achieved and analysis of EmrE protein
could be performed.
Fig. 2B–C shows SANS results of 8.5 μM and 21 μM EmrE in 0.2%
(w/v) d-SDS CM solutions after subtraction of the d-SDS CM solution.
The SANS data of 0.2% (w/v) d-SDS solubilized 8.5 μM EmrE exhibittwo scattering intensity decays of q−3 as qb0.007 Å−1 and q−1 as
qN0.1 Å−1. The q−3 dependence stems into even lower q ranges and
represents a fractal surface of large “clusters” (N1000 Å), which are
beyond the length scale of our current probing range [28]. The q−1
dependence illustrates a characteristic scattering of cylinders, pre-
sumably contributed from EmrE multimers. Fortunately, a nearly
plateau regime in scattering intensity between 0.05 and 0.1 Å−1 was
observed in SANS spectra of Fig. 2, allowing us to obtain the dimension
of the EmrE subunits by data ﬁtting this result to a cylindrical model
[29] (Fig. 2B). The best-ﬁtting radius and length of the cylindrical
EmrE multimers were (13±3) Å and (60±20) Å, respectively. Based
on the molecular weight and speciﬁc volume of EmrE (13,700 g/mol
and 0.77 ml/g, respectively) [30], this dimension leads to an average
subunit number of 2 (i.e., dimers). The large “clusters” with a fractal
surface could originate from either non-SDS-solvated EmrE aggre-
gates or SDS solvated EmrE multimers of larger size. Either
morphology for these larger EmrE multimers as interpreted from
SANS data is consistent with the results observed by SDS-Tricine PAGE
within the high MW region (Fig. 1).
The SANS data of 21 μM EmrE in 0.2% (w/v) d-SDS (Fig. 2C)
showed a similar scattering pattern to 0.2% d-SDS–8.5 μM EmrE,
except with a shorter q−1 range due to the scattering from the large
“clusters” that extend into a higher scattering intensity q range. It
should be noted that, although the EmrE concentration was only
threefold greater than the 8.5 μM EmrE/d-SDS sample, the scattering
intensities within the low-q (b0.006 Å−1) region of the spectrum
were about tenfold. This difference in scattering intensity indicates
that the population ratio of large EmrE “clusters” compared to
cylindrical multimers was inﬂuenced by EmrE concentration. Al-
though the q−1 decay is not as clear as that of the 8.5 μM EmrE
sample, ﬁtting these data with the cylindrical model provides us the
approximate volume of the protein multimer resulting in a best-
ﬁtting radius of (19±3) Å and length of (63±35) Å, where an
average EmrE subunit number of ∼4 (tetramer) was predicted. The
increase in EmrE multimer size (2→4 subunits) in 0.2% d-SDS
indicated that higher EmrE concentrations promoted larger average
EmrE subunit numbers, as observed by SDS-Tricine PAGE analysis
(Fig. 1). However, SANS data collected for 0.2% d-SDS–EmrE samples
with added TPP (1 mM) were nearly identical to those without TPP at
each corresponding EmrE concentration (Fig. 2C) revealing that TPP
Fig. 2. SANS spectra of 0.2% (w/v) d-SDS-solubilized EmrE protein in the presence and
absence of TPP. SANS spectra of 0.2% (w/v) d-SDS in CM buffer (open circles) and 0.2%
(w/v) h-SDS in CM buffer (solid circles) baseline solutions for determination of
contrast-matching (CM) conditions are shown in panel A. SANS spectra of 0.2% (w/v)
d-SDS in CM buffer (open circles) and 0.2% (w/v) h-SDS in CM buffer (solid circles).
Panel B shows SANS spectra collected for 8.5 μM EmrE/0.2% (w/v) d-SDS in CM buffer
before added ligand (open squares) and after 1 mM TPP addition (solid squares). Panel
C shows SANS spectra collected for 21 μM EmrE/0.2% (w/v) d-SDS in CM buffer before
ligand (open triangles) and after 1 mMTPP addition (solid triangles). The grey curves in
each panel indicate the best-ﬁt curve result using a cylindrical model of 8.5 and 21 μM
EmrE in SDS solutions without TPP. The SANS data and best-ﬁt results of 8.5 and 21 μM
EmrE solutions are re-scaled by 50 and 200, respectively for clarity.
Fig. 3. SANS spectra of 1.0% (w/v) d-SDS-solubilized EmrE protein in the presence and
absence of TPP. SANS spectra of 0.2% (w/v) d-SDS in CM buffer (open circles) and 0.2%
(w/v) h-SDS in CM buffer (solid circles) baseline solutions for determination of
contrast-matching (CM) conditions are shown in panel A. Panel B shows SANS spectra
of 1.0% (w/v) d-SDS-solubilized EmrE at 8.5 μM (squares) and at 21 μM (triangle)
concentrations. Panel C shows SANS spectra of 1.0% (w/v) d-SDS-solubilized 64.5 μM
EmrE (diamonds). SANS spectra shown in both panels B and C indicate 1.0% (w/v) d-
SDS-solubilized EmrE before ligand addition (empty symbols) and after 1 mM TPP
addition (ﬁlled symbol).The grey curve shown in panel C indicate best-ﬁtting curve
result of 64.5 μM EmrE using a cylindrical model in SDS solution without TPP. The grey
arrows show sharp peaks at q∼0.03 Å−1 (i.e., a regular correlation length ∼200 Å) and
broad peaks at q∼0.2 Å−1 (i.e., a loose correlation length ∼30 Å). The SANS data and
best-ﬁt result of 8.5, 21 and 64.5 μM EmrE solutions are re-scaled by 10, 100 and 1000,
respectively for clarity.
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low SDS concentrations (0.2% w/v).
SANS data collection of 1.0% (w/v) d-SDS in CM solution illustrated
a stronger q-dependence than that of 0.2% (w/v) d-SDS CM solution
(Fig. 3A), likely due to the increase in scattering signal from higher
micelle content. Applying the same data analysis performed for low d-
SDS (0.2% w/v) samples, SANS analysis was performed for 8.5 μM,
21 μM and 64.5 μM EmrE in 1.0% (w/v) d-SDS (Fig. 3B–C). Due to the
increase in d-SDS concentration (1.0% w/v), the higher concentration
EmrE sample (64.5 μM)could also be determined. SANS spectra of 1.0%
d-SDS–EmrE samples at 8.5 and 21 μM (Fig. 3B–C) showed differences
from the SANS spectra collected for EmrE in 0.2% (w/v) d-SDS
solutions (Fig. 3B). Although SANS spectra collected at both d-SDSconcentrations show EmrE scattering intensity (q−3) decay at low-q
values, no q−1 dependence in the high-q scattering rangewas found in
1.0% d-SDS–EmrE samples (Fig. 3B). Instead, the high-q value data had
a plateau region at q∼0.06 Å−1 followed by a seemingly broad peak at
q∼0.2 Å−1 (arrows in Fig. 3B–C), indicative of a loose length scale of
∼30 Å. This shows the morphology of EmrE multimers likely changed
upon the increased concentration of d-SDS. Moreover, a sharp peak
(with a narrow width of ∼0.01 Å−1) was observed at q∼0.03 Å−1
(arrows in Fig. 3B–C), indicating an extremely regular spacing of
∼200 Å, for EmrE samples at concentrations of 21 and 64.5 μM. That
Fig. 4. Far-UV CD spectra of 0.2% (w/v) and 1.0% (w/v) SDS-solubilized EmrE protein in
the presence and absence of TPP. Far-UV region (185–255 nm) mean residue ellipticity
CD spectra are shown in panel A corresponding to 8.5 μMEmrE protein re-suspended in
either 0.2% (w/v) SDS (solid line) or 1.0% (w/v) SDS (dashed line). Panel B shows far-
UV mean residue ellipticity CD spectra collected for SDS solubilized 8.5 μM EmrE re-
suspended in 0 mM TPP (solid line), 0.1 mM TPP (dashed line) and 1 mM TPP (line–
dot–line) respectively.
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ences indicates a stable, lattice-like structure exists under these high
1.0% (w/v) d-SDS conditions. Since this correlation length is not
observed for 0.2% (w/v) d-SDS–21 μM EmrE samples, it presumably
originates from consistently spaced EmrE multimer formation. As for
1.0% d-SDS–64.5 μM EmrE, the characteristic of cylindrical scattering
pattern observed in SANS spectra of low 0.2% d-SDS–EmrE samples
was recovered (Fig. 3C). The best-ﬁtting average dimensions of the
cylinders were (12±1) Å in radius and (64±15) Å in length. This
resulted in an average EmrE subunit number of 1.6 indicating that a
high SDS concentration helps solvate EmrE, thus leading to the
prediction of a more condensed cylinder.
SANS data collected fromEmrE in 1.0% (w/v) d-SDS in the presence
of 1 mM TPP showed almost identical high-q data (qN0.05 Å−1) after
comparison to corresponding samples lacking TPP. This indicated no
variation of EmrE in local conformations (Fig. 3B–C). Nevertheless, the
low-q data obtained from SDS–EmrE samples without TPP ligand have
lower q intensity at EmrE concentrations of 8.5 and 21 μM, unlike the
higher q intensity of 64.5 μM EmrE samples. These deviations in
intensity were presumably due to the variation of population and/or
size of the large “clusters” as a result of addition of TPP. However, SANS
data of an even lower q range will be required to resolve this issue.
2.4. CD spectropolarimetry of SDS–EmrE results in similar levels of α-
helix content in the presence or absence of TPP
CD spectropolarimetry was used to monitor any changes in the
amount of secondary structure content of the SDS–EmrE preparations
under low and high SDS solubilising conditions and in the presence or
absence of TPP. CD spectra obtained for 8.5 μM EmrE re-suspended in
either 0.2% (w/v) SDS or 1.0% (w/v) SDS were very similar. CD
spectrum similarity was conﬁrmed after performing a paired
Student's t-test that resulted in P-valuesN0.05 (Fig. 4A). EmrE protein
re-suspended in either concentration of SDS resulted in the
characteristic CD spectrum for α-helix rich protein (dual λ minima
at 208 and 220 nm), where α-helix content estimates ranged from 68
to 73% and from 21 to 26% corresponded to unordered structure after
deconvolution. These secondary structure predictions were similar to
estimates reported by [24]. The addition of TPP ligand at 0.1 mM and
1 mM ﬁnal concentration to EmrE in low (0.2%) or high (1.0%) SDS,
resulted in CD spectra that were similar to ligand free preparations of
SDS–EmrE (Fig. 4B). Estimatedα-helix content from the CD spectra of
SDS–EmrE in the presence of TPP ligands all resided within the range
determined for SDS–EmrE without added ligand after spectrum
deconvolution. This suggests that TPP ligand addition does not
signiﬁcantly alter the α-helical content of the EmrE, and that EmrE
protein is rich in α-helix content as predicted. The lack of signiﬁcant
secondary structure alteration suggests that TPP interaction with
SDS–EmrE likely results in tertiary to quaternary structure alterations
only, as shown by SDS-Tricine PAGE and ﬂuorescence of the protein
experiments herein.
2.5. TPP quenches EmrE aromatic residues to different extents in SDS by
ﬂuorescence spectroscopy
Fluorescence spectroscopy was used to probe for changes in EmrE
aromatic amino acid residue environments in the presence and
absence of TPP. To accomplish this, we began by determining the
intrinsic ﬂuorescence of EmrE in SDS solution to determine confor-
mational differences in low and high concentration SDS environ-
ments. EmrE protein possesses sufﬁcient Trp (4 residues) and Tyr (5
residues) residues to be chromophoric. Some of these residues were
previously shown to inﬂuence both EmrE multimerization (Y40;
[31,32]) and its active site (Y4, Y40, and W63; [32–34]). Furthermore,
previous ﬂuorescent spectroscopy of EmrE protein and site-directed
mutant variants lacking each of the four Trp residues, indicated thatits substrate bindingwas highly inﬂuenced byW63 in particular in the
presence of ethidium [35]. Hence, the effects of TPP interaction with
the protein can be measured by surveying changes in its aromatic
residue ﬂuorescent intensity. SDS–EmrE protein ﬂuorescence was
monitored at an excitation wavelength of 280 nm to determine the
extent of TPP changes to the SDS–EmrE ﬂuorescent spectrum.
Emission spectra collected for 0.2% (w/v) SDS solubilized 0.35 μM
EmrE lacking added ligand were similar to the spectra for EmrE
solubilized at a higher (1.0% w/v) SDS concentration (Fig. 5).
However, the degree of Y to W energy transfer was somewhat
variable within these preparations, speciﬁcally for tyrosine ﬂuores-
cence contributions, which suggest separation of the transmembrane
packing at high detergent concentrations. The trend of ﬂuorescence
signal quenching observed for TPP addition to low SDS–EmrE samples
resulted in a similar low level of ﬂuorescent quenching (10–25%
intensity reduction). Speciﬁcally, increasing the concentration of TPP
to 0.2% SDS-solubilized EmrE samples resulted in a slight decrease in
ﬂuorescence intensity that never exceeded 75% of the total ﬂuores-
cence signal at the highest concentration of drug surveyed (0.16 mM
ligand) (Fig. 5A). Increasing TPP drug concentrations in 0.2% SDS–
EmrE did result in a partial to complete loss of Y signal contribution
(300–310 nm region) that resulted in a dominant W residue
ﬂuorescence signal (Fig. 5A).
Emission spectra obtained for 1.0% (w/v) SDS-solubilized 0.35 μM
EmrE demonstrated high contributions of Y ﬂuorescence intensity
(λmax ∼303–315 nm) in addition to W (shoulder region from 330 to
345 nm) ﬂuorescence within the protein (Fig. 6B). The recurrent
dominance of Y emission in 1.0% SDS–EmrE as compared to 0.2% SDS–
EmrE, likely results from loss of energy transfer between the Y to W,
Fig. 5. Fluorescence emission spectra of 0.2% (w/v) and 1.0% (w/v) SDS-solubilized
EmrE protein in the presence and absence of TPP. The emission intensity of EmrE
samples excited at 280 nm wavelength are shown in arbitrary units and collected
within the wavelength region of 290–400 nm. Fluorescent spectra are shown for 0.2%
(w/v) solubilized 0.35 μM EmrE samples (panel A) and 1.0% (w/v) solubilized 0.35 μM
EmrE (panel B). In both panels TPP was added to both protein sample at ﬁnal
concentrations of 0 mM drug (solid line), 0.016 mM drug (dashed line), 0.081 mM drug
(line–dot–line), and 0.16 mM drug (dotted line).
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regions of the protein. Upon increasing the ligand concentration of
TPP (Fig. 5A), the ﬂuorescent intensity andmaximum of EmrE showed
a gradual loss of Trp intensity (30–45% of the total intensity) (Fig. 5B).
TPP at high concentrations resulted in a slight increase in ﬂuorescence
intensity by both Y andW residues. The enhanced quenching effect on
Trp and Tyr in 1.0% (w/v) SDS–EmrE strongly suggests that higher
SDS detergent concentrations enhance the drug binding capability of
the protein. As determined by SANS data analysis, the EmrE protein
conformation at high SDS differs slightly from those predicted from
low SDS–EmrE conformations summarized in Fig. 6.3. Discussion
Based on the results of these experiments, SDS-solubilized EmrE
protein can adopt a diverse range of multimer forms, beginning with
primarily monomeric forms at low protein concentrations ranging to
increasingly larger multimeric complexes at higher protein concen-
trations. According to the dimensions estimated from SANS spectra of
SDS–EmrE summarized in Fig. 5, we suggest that EmrE dimers form
cylinder-like structures in SDS at both low (0.2% w/v) and high (1.0%
w/v) concentrations that were tested. It is interesting to note that at
low SDS concentrations, the shape of EmrE dimers and tetramers
appears to be far less condensed than at higher SDS concentrations
studied, suggesting that both the detergent and protein concentration
signiﬁcantly inﬂuence TM packing within the protein. The cylinder-
like shape of SDS–EmrE dimers contrasts the cube-like conformations
of 2D and 3D cryo-EM crystal structures [11–13,36] and X-ray
diffracted crystal structure [10] of EmrE, suggesting that SDS
inﬂuences different TM packing constraints than those detergents
used in other studies. High resolution solution-based structural
studies involving NMR show that many membrane proteins have
ﬂexible or discordant TM segment arrangements in solution than
from crystal structures (as reviewed by [37]). Differences such as this
may account for cylinder, rather than cube like shapes of EmrE
multimer complexes in crystallized EmrE preparations. We recognize
that SDS detergent is an unlikely folding environment, in comparison
to the plasma membrane, but what is certain is that stable dimer and
trimer/tetramer forms of EmrE can be induced in SDS detergent atincreasing protein concentrations and yields EmrE oligomer forms
observed in other studies of detergent solubilized EmrE [21,33,38].
Moreover, the aromatic residues within EmrE are inﬂuenced by
the addition of TPP ligand, indicating that the protein does interact
with ligand in SDS. The addition of TPP to SDS–EmrE preparations at
the detergent concentrations tested does not appear to alter the
packing conformation of smaller oligomers, speciﬁcally dimers and
tetramers as observed in both SANS and SDS-Tricine PAGE analyses
(Figs. 1–3). TPP does appear to stabilize the formation of EmrE
multimers in SDS, particularly EmrE complexes at or exceeding
estimated octamer/hexamer forms. These larger EmrE multimers,
observed by SDS-Tricine PAGE at higher MW regions (N96 kDa), are
also found in SANS analysis where these larger EmrE complexes likely
correspond to the lattice structures (correlation lengths ∼200 Å) at
the higher SDS concentration (1.0% w/v) examined. EmrE multimer
complexes visualized by SDS-Tricine PAGE revealed that higher initial
starting amounts of EmrE protein ≥0.5 mg were critical to detect SDS
induced EmrE multimers. This corresponds to previous experiments
where higher multimers were unobserved in EmrE samples using
lower initial starting protein amounts [39] that indicated only
monomer forms of EmrE exist in SDS.
EmrE protein adopted numerous multimeric forms in this study,
many that were previously observed in experiments involving
dodecyl maltoside solubilized tagged EmrE [12,24,39–41]. It is
noteworthy that EmrE multimers were also observed in a recent
study of Cyan ﬂuorescent protein-tagged EmrE on SDS-PAGE [30], but
the presence of EmrE oligomers in these experiments was not
discussed. Predicted trimer forms of EmrE were identiﬁed from our
gels, similar to SDS-PAGE results obtained for C-terminus FLAG tagged
Staphylococcus aureus homologue of EmrE, Sau-Smr re-suspended in
dodecyl maltoside [42]. Our SDS-PAGE experiments showed a
noticeable lack of tetramer forms of EmrE according to its estimated
MWand instead suggested that EmrE trimer and hexamer formswere
present in SDS. However, EmrE tetramers were predicted from the
results of our SANS experiments (Fig. 6) and strongly suggest that
both EmrE trimer and hexamer forms may correspond to condensed
EmrE tetramers and octomeric bundles in these SDS preparations
using SDS-PAGE. This is a reasonable assumption as even the
monomer form does not migrate exactly to its expected molecular
weight. Highly condensed “α-helix bundle-like” forms of EmrE
tetramers are predicted for this protein based on other biochemical
and in silico studies [40,43,44] and would result in a faster
electrophoretic mobility of tetramer and octamer forms, consequently
reducing its apparent MW in the gel. This phenomenon is often
observed in α-helical membrane protein folding studies using SDS-
PAGE analysis. In a recent study using various α-helical proteins,
changes to the conformation of the protein altered the amount of SDS
capable for binding and resulted in ‘gel shifting’ of these proteins from
proposed wild-type conformations [45]. The high proportion of
hydrophobic residues within EmrE protein also promote more SDS
detergent binding [39] than other integral membrane proteins,
thereby altering its electrophoretic mobility in SDS-Tricine PAGE
gels as the multimer form increases. As discussed in a recent article
focusing on EmrE folding [46] and review [9], this protein is very
robust, and can withstand protease cleavage and denaturing environ-
ments intolerable for many integral membrane proteins. Therefore,
SDS serves as a useful membrane-mimetic system for other studies
involving EmrE protein.
Another striking observation from this study was the enhance-
ment of EmrE multimer formation in SDS upon the addition of TPP
ligand. SDS-Tricine PAGE results show clear differences in EmrE
multimerization, where increasing TPP enhances EmrE multimeriza-
tion and/or stabilizes existing multimers. This strongly suggests that
the drug interaction sites in the SDS–EmrE preparations studied
herein are closely linked to regions of the protein involved in EmrE
oligomerization. This contrasts DDM solubilization of His-tagged
Fig. 6. A cartoon diagram of predicted EmrE dimensions determined from SANS analysis. The estimated dimensions of EmrE protein complexes correspond to large cylinders shown
in the far left-hand side of each panel where the radius (r) and height (h) of the cylinder are given above each arrow in angstroms (Å). Thin grey and white cylinders ﬁtted with the
larger EmrE cylinder to the right-hand side correspond to individual α-helix TM strands (with dimensions corresponding to a r=4.6 Å and h=35 Å of a 6 turn α-helical TM
segment). TM segments were rotated manually at tilt angles of 0°–30° within the indicated r and h of each cylinder shown to the left to determine the degree of TM tilt and
approximate number of TM strands each EmrE cylinder could accommodate. Top views shown in each panel are designated as a circle of the same dimensions indicated in the left-
hand cylinder and show the number of TM strands that a given complex can accommodate based on TM tilt. Panel A indicates the predicted EmrE complex dimensions for the q−1
dependence cylinder of 0.2% (w/v) SDS–8.5 μM EmrE and TM ﬁtting, panel B shows the q−1 dependence cylinder of 0.2% (w/v) SDS–21 μM EmrE, and panel C shows the q−1
dependence cylinder determined for 1.0% (w/v) d-SDS–64.5 μM EmrE.
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ligand had no effect on protein multimerization [41]. SDS solubiliza-
tion of membrane proteins has also been shown to promote transition
state or intermediate folding states of certain α-helical proteins; the
SDS–EmrE conformations studied here may reﬂect these intermedi-
ates necessary for oligomerization unlike DDMwhere the proteinmay
exist in a non-transitioning state unalterable by ligand interaction.
SANS analysis of SDS–EmrE samples in the presence of TPP also
shows variations in the population of the large EmrE “clusters”.
Fluorescence quenching of SDS–EmrE aromatic residues by TPP
appears to reduce the overall Tyr signal intensity under low SDS
concentrations, but not the Trp signal. At high SDS concentrations, TPP
quenching of both Trp and Tyr are more pronounced. This suggests
that TPP interacts with the protein at both SDS concentrations but
differences of EmrE conformations such as TM packing may alter the
extent of Trp quenching by TPP. Many aromatic residues within SMR
proteins are highly conserved (W63, Y4, Y40, and Y60 according to E.
coli EmrE), and are essential for protein activity regarding both EmrE
ligand binding [24,35,47] and multimerization [32,34]. Therefore, theﬂuorescent quenching trends we observe for TPP conﬁrms that
aromatic residues respond to ligand in these SDS–EmrE preparations
as in other EmrE experiments involving non-ionic detergents and
ligands.
To date, all in depth analyses of EmrE protein structure have been
performed in membranemimetic environments, either in detergents
or phospholipids, making it difﬁcult to compare the exact multimeric
composition of EmrE in vivo. The limitations posed by its short
length (110 amino acids) strongly suggest that multimerization is a
necessary requirement for its transport activity and has been
observed in numerous biochemical and biophysical studies (as
reviewed by [8]). However, the precise number of EmrE multimer
subunits still remains uncertain within the plasma membrane itself.
Based on our studies, we have demonstrated that numerous EmrE
oligomers are formed by this protein and stabilized by TPP ligand.
This could suggest that EmrE is capable of multimeric ﬂexibility, by
altering its subunit amount to correspond to ligands, or that when
unconﬁned in a detergent environment it has more space to
accommodate such a large TPP ligand.
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This study indicates that SDS–EmrE forms multimers in a protein
concentration-dependent manner. Thus, EmrE is a robust protein
capable of oligomerizing in the anionic detergent SDS. SDS–EmrE
multimers appear to be stabilized and enhanced in the presence of
its ligand TPP, suggesting that ligands may inﬂuence EmrE
multimerization.
5. Materials and methods
5.1. Materials used in this study
All chemicals used in this study were purchased from Sigma
Aldrich (St Louis, MO, USA) with the following exceptions listed.
Organic solvents namely, chloroform, methanol, trichloromethanol
and cell growth components tryptone, yeast extract and glycerol were
purchased from EMD Chemicals (Darmstadt, Germany). Electropho-
resis components such as SDS, tricine, trizma base, acrylamide, and
bisacrylamide were obtained from BioRad (Hercules, CA, USA).
Deuterated water and deuterated SDS detergent used for SANS
experiments were also obtained from Sigma Aldrich.
5.2. Expression and puriﬁcation of EmrE protein
The plasmid vector pMS119EH [48] encoding the recombinant
untagged E. coli emrE gene (pEmr-11) was described previously in
[26]. EmrE protein accumulation was performed using the trans-
formed E. coli cell strain LE392Δuncwith the pEmr-11 vector grown in
6 l of terriﬁc broth and 100 μg/ml ampicillin to an optical density at
600 nm (OD600nm) of ∼0.5 units. Upon reaching OD600nm of 0.5 cells
were induced to express the recombinant emrE gene with isopropyl
thio β-galactoside (IPTG) to a ﬁnal concentration of 0.1 mM IPTG. Cells
were grown for an additional 3 h after induction, harvested by
centrifugation at 4000×g and stored frozen at −70 °C in SMR-A
buffer (50 mM MOPS, 8% glycerol, 5 mM EDTA, 1 mM dithiothreitol
(DTT), pH 7). The frozen cell slurry was thawed on ice and
phenylmethyl sulphonylﬂuoride (PMSF) was added to a ﬁnal
concentration of 0.1 mM and French pressed at 800–1000 psi using a
Sim-Aminco French Press instrument. Pressed cell slurry was
centrifuged at 11,000×g for 10 min at 4 °C to remove unbroken cells
and subsequently centrifuged in a Beckman-Coulter Optima™ L-90K
ultracentrifuge at 40,000 rpm for 90 min at 4 °C in a Ti70 rotor to
separate the membrane fraction from the cytosolic fraction. The
membrane fraction was re-suspended in SMR-A buffer at a ﬁnal
protein concentration of 10 mg/ml based on modiﬁed Lowry Assays
[49] and frozen in liquid N2 for storage at−70 °C.
Frozenmembrane preparations were thawed at room temperature
(20–25 °C) and subjected to an organic extract procedure in 3:1
chloroform: methanol as described previously [26]. The organically
extracted membrane solution was concentrated to 4–10 ml using a
Rotovap condenser system. EmrE protein was puriﬁed by high
pressure liquid chromatography (HPLC) on an AKTA™ Unicorn
instrument using an SR10/50 column of LH20 sephadex resin in 1:1
chloroform: methanol solvent. EmrE protein was found to elute
within the ﬁrst peak as monitored by UV absorption at 280 nm
(A280nm). EmrE organic extract fractions were collected together at
concentrations ranging from 0.01 mg/ml to 10 mg/ml EmrE protein
and dried under N2 gas in the fume hood for storage at −20 °C.
5.3. SDS detergent re-suspension of EmrE protein and ligand addition
Dried EmrE protein at a variety of initial starting concentrations
ranging from 0.001 mg to 15 mg protein was used for these experi-
ments. EmrE protein was re-suspended into 0.2% or 1.0% (w/v) SDS
detergent in SMR-Bbuffer (5 mMMOPS, 10 mMNaCl, 10 μMDTT,pH7).These solutions were vigorously shaken for 1–2 h to solubilise the
protein and then refrozen for 6–14 h at −20 °C. Thawed protein
samples were mixed by vortexing for 1 min and sonicated to optical
clarity using three, 10 second bursts of 30% sonicating intensity of a
Microson XL Ultrasonic cell disrupter. These solutions were centrifuged
at 10,000×g at room temperature for 10 min to pellet any undissolved
material. EmrE protein concentrations were determined by ultraviolet
(UV) absorbance spectroscopy with an Ocean Optics UV–visible (Vis)-
Spectrophotometer at A280nm using the extinction co-efﬁcient (ε) of
29,638 cm−1 M−1.
The QCC ligand used for this study was TPP and was previously
shown to bind to the organically extracted EmrE experimentally in
SDS, dodecyl maltoside (DDM) and reconstituted vesicles [22].
Additionally, organically extracted EmrE under these conditions was
shown to be stable and fold in eachmembranemimetic examined [24].
TPP was solubilized in SMR-B buffer to a ﬁnal concentration of 0.5 M
and served as stock solution. TPP was incubated with either 0.2% or
1.0% (w/v) SDS-solubilized EmrE protein at concentrations of 0.1 mg/
ml (8.5 μM), 0.25 mg/ml (21 μM), and 0.75 mg/ml (61.5 μM) and
incubated at room temperature for a minimum of 1 h. TPP was added
to each EmrEprotein concentration listed above, ranged from0.01 mM
to 10 mM, depending on the experiment used for study. It should be
mentioned that TPP added to SDS solution alone, resulted in the
formation of a cloudy precipitate that could not be removed by
centrifugation. The precipitate was noted in 0.2% (w/v) SDS solutions
with andwithout solubilized EmrE protein at TPP concentrations at or
above 1.0 mM and 1.0% (w/v) SDS with TPP at concentrations
≥5.0 mM ligand. However, the TPP induced precipitate in 1.0% (w/
v) SDS was reversible after brief sample stirring in the presence of
EmrE protein containing samples only. The ﬁnal molar ratios of
detergent to EmrE protein were 824:1 and 4117:1 calculated based on
detergent concentrations of 0.2% (7 mM) and 1.0% (35 mM) SDS to
8.5 μM EmrE protein respectively. The ﬁnal molar ratios of TPP ligand
to EmrE ranged from 4.6 to 1250 (calculated from 0.1 mM to 10.0 mM
ﬁnal TPP concentrations and 8.5 μM and 21 μM EmrE protein).
5.4. SDS-Tricine PAGE analysis of EmrE protein
SDS-Tricine PAGE was selected to screen EmrE multimers to
permit molecular weight (MW) determination of the various EmrE
multimers in these experiments. Due to the presence of SDS within
the gel, this systemmirrors a “native” environment for our conditions
rather than ‘native’-PAGE techniques, which are less reliable for
accurate MW estimations due to carryover detergent with the protein
complexes and inherent charge differences on the protein in its
various conformations. All SDS-solubilized EmrE samples with and
without TPP were analyzed using 12% SDS-Tricine PAGE. Trichlor-
oethanol (TCE) was added to the gels during casting, at a ﬁnal
concentration of 0.5% (v/v) TCE, to visualize EmrE tryptophan
residues (4 Trp/protein) by UV irradiation at 300 nm according to
themethod described by Ladner et al. [50]. The TCE staining technique
increased the ability to visualize the EmrE proteinmultimers in the gel
by 62% in comparison to conventional coomassie staining, with no
difference in migration of the protein. EmrE protein samples were
loaded onto the SDS-Tricine PAGE gels to a ﬁnal amount of 3 μg in the
presence or absence of ligand surveyed.
To address the potential issue of SDS removal from the protein by
TPP, Tricine SDS-PAGE experiments were performed to solubilize
EmrE with greater amounts of SDS to saturate the protein while
keeping the same TPP concentrations. To ensure that TPP is the
underlying cause of the multimerization at the current (0.2% or 1.0%
w/v) SDS concentration, EmrE multimerization was tested at higher
SDS concentrations. Supplementary Fig. 1 shows the results from
these experiments, and indicates that EmrE multimerization is
identical at SDS concentrations of 4.0% (w/v) and 8.0% (w/v) in the
presence or absence of TPP (at the same concentrations cited above)
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concentrations used in the original experiments. Experiments were
also performed to increase SDS concentrations to either 4.0% and 8.0%
(w/v) SDS by adding buffered SDS to ligand pre-incubated 0.2% SDS
and 1.0% SDS solubilized EmrE samples and showed no differences in
EmrE band intensity. Since no alterations to EmrE multimerization
can be observed in either experiment, it is unlikely that TPP is
removing SDS from the protein at the detergent concentrations used
in this study.
EmrE protein band intensity was normalized by its intensity and
molecular weight in kilodaltons (kDa), according to the amount of
BioRad low range and polypeptide molecular weight standards to
correct for TCE staining differences. Once protein bands were
normalized, the overall intensity of each protein band was reported
as the percentage of the total amount of protein loaded (3 μg protein).
Experiments were repeated a minimum of three times and average
EmrE protein band percentage values are reported in Table 1. All
protein band intensity measurements were collected from TCE
stained SDS-Tricine (12%) PAGE gels using the Kodak 1D™ software
package.
5.5. Small angle neutron scattering (SANS) analysis of EmrE protein
Puriﬁed EmrE protein was re-suspended into 0.2% or 1.0% (w/v)
deuterated SDS (d-SDS) in contrast-matched (CM) solvent, whose
scattering length density matches with that of the d-SDS. The
contrast-matched solvent consisted of a mixture of hydrogenated
water (H) and deuterated water (D) with a volume ratio D/H=9/1
that was experimentally determined to minimize the coherent
scattering intensity from the d-SDS solutions through a series of D/
H compositions. The CM solvent was prepared in SMR-B buffer
(5 mM MOPS, 10 mM NaCl, 10 μM DTT, pH 7), such that its total
hydrogen content was below 0.05% of the total hydrogen content of
the solution, which did not alter contrast-matching conditions. The d-
SDS re-suspended EmrE protein solutions for SANS experiments were
prepared as described in the above sections; EmrE protein concentra-
tions were determined by UV Absorption spectroscopy at A280nm
(ε280nm 29,638 cm−1 M−1 EmrE). All samples were baseline cor-
rected using their respective d-SDS CM SMR-B buffered solution. TPP
was prepared to a ﬁnal concentration of 1 M in CM SMR-B buffered
solution and added to each sample at a ﬁnal concentration of 1 mM.
All SANS experiments were performed at the NG7 30-m Small
Angle Neutron Scattering Instrument (NG7 SANS) located at the
National Institute of Standards and Technologies (NIST) Centre for
Neutron Research (NCNR) in Gaithersburg, Maryland, USA. SANS data
are normally reported as the scattered intensity I (q) versus q (Å−1),
where q represents the scattering vector deﬁned as 4πλ sin
θ
2
 
, with λ
and θ as the wavelength of neutrons and the scattering angle,
respectively. All samples were loaded in standard NCNR demountable
cells (with quartz windows) with a sample thickness of 4 mm. The
SANS data were collected at a wavelength of 6 Å and three sample-to-
detector distances of 1, 5 and 13.2 m to cover a q-range between 0.003
and 0.4 Å−1. Raw SANS data were then corrected by the empty cell
and background scattering, normalized by the neutron ﬂux and the
sample thickness, and put on the absolute scale. Incoherent scattering
was determined by the high-q plateau and subtracted from the
reduced data.
To determine the shape of EmrE multimers in SDS based on the
SANS spectra, SANS data were compared to SANS spectra collected
from compounds and polymers of known volume.We identiﬁed that a
cylindrical model produced the best curve ﬁtting with the lowest
RSMD. EmrE transmembrane segments were manually ﬁtted into the
predicted cylinders in both ‘length-wise’ directions shown in Fig. 6
and in the opposite ‘width-wise’ direction. Width-wise EmrE TM
strand ﬁtting into the cylinders poorly accommodated the space
requirement posed by the protein to ﬁt all the necessary TM strandssince they exceeded the turn angle maximum for the protein. Due to
the short connecting loops and turns separating each of the four
transmembrane strands based on EmrE secondary structure, limita-
tions to TM tilt anglewere considered during TM ﬁtting in bothwidth-
wise and length-wise cylinder ﬁts. As a result only the lengthwise
ﬁttings are presented herein.
5.6. Circular dichroism spectropolarimetry of EmrE protein
CD spectra were acquired on a JASCO J-810 spectropolarimeter
calibrated with (1)-10-camphorsulfonic acid and purged with N2 at
40–60 l/min. CD spectra of 0.2% and 1.0% SDS-solubilized 8.5 μMEmrE
samples used for SDS-Tricine PAGE experiments were measured in
the far-UV region (185–260 nm) using 0.10-cm path length quartz
cuvettes at room temperature 22 °C, a scan rate of 10 nm/min, a
response time of 8 s, and CD spectra were measured in triplicate. CD
spectra were corrected by baseline subtraction from their appropriate
SDS solution, and were converted tomean residue ellipticity using the
molecular weight of EmrE (31,402 g/mol) and 110 amino acid
residues. SDS-solubilized EmrE spectra with and without added TPP
ligand (0.1 and 1 mM TPP ﬁnal concentrations) were measured a
minimum of three times. Samples containing 1 mM TPP resulted in
high amounts scattering below the 200 nm region and required
smoothing for subsequent CD spectrum deconvolution. To determine
the secondary structure content of EmrE, CD spectrum deconvolution
was performed using the Dichroweb package available online [51,52];
deconvolution values from the SELCON and CONTINLL algorithms are
cited in the text. The normalized root mean square deviation
(NRMSD) values of deconvoluted CD spectra used in this analysis
were ≥0.120.
5.7. Fluorescence spectroscopy of EmrE protein
Fluorescence spectroscopic analysis of SDS-solubilized EmrE
protein in the presence and absence of TPP was performed using a
Fluorolog-Tau-3 Time-resolved spectroﬂuorometer. Fluorescent spec-
tra were collected in a 1 cm path length quartz cuvette, at an
excitation (Ex) wavelength of 280 nm. The emission (Em) spectrum
was measured from 290 to 400 nm using double monochrometers for
both Ex and Em to reduce scattering artefacts. Both Ex and Em of each
sample measured were collected using a 2 nm slit width. All spectra
were the average of 6 scans. Fluorescence spectroscopy of SDS-
solubilized EmrE protein was performed a minimum of 3 times for
each ligand tested.
EmrE protein samples used for ﬂuorescence experiments were
selected from SDS-Tricine PAGE experiments and diluted to 0.35 μM
EmrE protein from starting concentrations ranging from 21 μM
(0.25 mg/ml) EmrE protein samples in either 0.2% and 1.0% (w/v)
SDS. TPP ligand was added to SDS–0.35 μM EmrE protein samples at
the samemol ratios used for SANS and SDS-Tricine PAGE experiments
(12 mol ligand:1 mol EmrE to 588 mol TPP:1 mol EmrE), which
corresponded to ﬁnal QCC concentrations of 0.016 mM, 0.081 mM,
and 0.16 mM. A concentration of 0.35 μM EmrE was necessary since
higher protein concentrations resulted in increased levels of noise in
ﬂuorescence signal intensity when TPP was added.
To address whether the Cl− counter ion of TPP+ had any
quenching affects on Trp and Tyr quenching within all SDS–EmrE
samples, the experiments described were repeated above using the
same molar concentrations of NaCl and KBr salts in the place of TPP+
(Cl−) ligand. No alteration to the SDS–EmrE ﬂuorescent spectra was
observed in these experiments (data not shown).
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